Merck & Co., Inc. (MRK): return on equity, 10 filed years
ROE at Merck & Co., Inc. was 34.7% in FY2025, the newest filed year. Across the 10 computed years from FY2016 it ranged from 1.0% (FY2023) to 38.0% (FY2019), with a median of 29.7%.
Tonight's figure on the company page: 34.7%, recomputed 2026-10-15. The table is each filed year on its own terms, with the formula below; the current figure may use trailing twelve months or, where the explainer says so, a different denominator.
Year by year
| Fiscal year | ROE | Read from |
|---|---|---|
| FY2016 | 9.8% | 10-K, filed 2017-02-28 |
| FY2017 | 7.0% | 10-K, filed 2018-02-27 |
| FY2018 | 23.3% | 10-K, filed 2019-02-27 |
| FY2019 | 38.0% | 10-K, filed 2020-02-26 |
| FY2020 | 27.9% | 10-K, filed 2021-02-25 |
| FY2021 | 34.2% | 10-K, filed 2022-02-25 |
| FY2022 | 31.6% | 10-K, filed 2023-02-24 |
| FY2023 | 1.0% | 10-K, filed 2024-02-26 |
| FY2024 | 37.0% | 10-K, filed 2025-02-25 |
| FY2025 | 34.7% | 10-K, filed 2026-02-24 |
How each year is computed
Net income / shareholders equity x 100
Each year is a ratio of lines in that year's filed annual report, with the nightly recompute's own rules for what counts as a filed line. Nothing is estimated, smoothed or filled in: a year that cannot be computed says why.
Read further
A computation on accounts filed with the SEC, not a recommendation and not advice. Past filings do not indicate future results. Risk disclaimer.